Daily transient coating of the intestine leads to weight loss and improved glucose tolerance.
Daily transient coating of the intestine leads to weight loss and improved glucose tolerance.
复制标题
DOI:
10.1016/j.metabol.2021.154917
复制
发表时间:
2022-01
期刊:
影响因子:
--
通讯作者:
Tavakkoli A
中科院分区:
文献类型:
--
作者:
Lo T;Lee Y;Tseng CY;Hu Y;Connelly MA;Mantzoros CS;Karp JM;Tavakkoli A
Roux-en-Y gastric bypass surgery (RYGB) has been shown to be the gold standard treatment for obesity associated type-2-diabetes (T2D), however many T2D patients do not qualify or are reluctant to proceed with surgery due to its potential risks and permanent changes to GI anatomy. We have previously described a novel oral formulation, LuCI, that provides a transient coating of the proximal bowel and mimics the effects of RYGB. Herein, we aim to investigate outcome of chronic LuCI administration on weight and glucose homeostasis. Sprague-Dawley rats on a high fat diet achieving diet-induced obesity (DIO) received 5 weeks of daily LuCI or normal saline as control (n = 8/group). Daily weights and glucose tolerance were monitored throughout the experiment. At 5 weeks, systemic blood was sampled through a surgically placed jugular vein catheter, before and during an intestinal glucose bolus, to investigate changes in key hormones involved in glucose metabolism. To elucidate the effects of LuCI on nutrient absorption, fecal output and food intake were measured simultaneously with the analysis of homogenized stool samples performed using bomb calorimetry. At 5 weeks, LuCI animals weighted 8.3% less and had lower fasting glucose levels than Controls (77.6 ± 3.8 mg/dl vs. 99.1 ± 2.7 mg/dl, P<0.001). LuCI-treated animals had lower baseline insulin and HOMA-IR. Post-prandially, LuCI group had increased GLP-1 and GIP secretion following a glucose challenge. Serum lipid analysis revealed lowered LDL levels highlighting the potential to not only improve glucose control but also modify cardiovascular risk. We then investigated whether LuCI’s effect on proximal bowel exclusion may play a role in energy balance. Bomb calorimetry analysis suggested that LuCI reduced calorie absorption with no difference in caloric consumption. We demonstrated that LuCI recapitulates the physical and hormonal changes seen after RYGB and can ameliorate weight gain and improve insulin sensitivity in a DIO rat model. Since LuCI’s effect is transient and without systemic absorption, LuCI has the potential to be a novel therapy for overweight or obese T2D patients.
登录
查看更多内容
影响因子:
3.9
作者:
Bedi S;Garcia E;Jeyarajah EJ;Shalaurova I;Perez-Matos MC;Jiang ZG;Dullaart RPF;Matyus SP;Kirk WJ;Otvos JD;Davidson WS;Connelly MA
通讯作者:
Connelly MA
DOI:
10.1056/nejmsa2032271
发表时间:
2021-06-10
期刊:
The New England journal of medicine
影响因子:
--
作者:
Fang M;Wang D;Coresh J;Selvin E
通讯作者:
Selvin E
影响因子:
4.9
作者:
Cummings, D. E.
通讯作者:
Cummings, D. E.
影响因子:
39.2
作者:
COLDITZ, GA;WILLETT, WC;MANSON, JE
通讯作者:
MANSON, JE
影响因子:
16.9
作者:
Courcoulas AP;Belle SH;Neiberg RH;Pierson SK;Eagleton JK;Kalarchian MA;DeLany JP;Lang W;Jakicic JM
通讯作者:
Jakicic JM